RT @BoschBarrera: Vamos en la buena dirección, pero queda mucho camino para el objetivo del 75% de supervivencia en 2030 para el cáncer de…
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/SFuKy6J7y1
RT @prat_aleix: valid points from @VPrasadMDMPH regarding these two articles published in @ASCO_pubs + @NEJM in lung cancer worth listenin…
Impressive evidence that precision oncology is improving outcomes for non-small cell lung cancer patients: “treatment advances ... are likely to explain the reduction in mortality." https://t.co/aip28DMiQF
RT @prat_aleix: valid points from @VPrasadMDMPH regarding these two articles published in @ASCO_pubs + @NEJM in lung cancer worth listenin…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @prat_aleix: valid points from @VPrasadMDMPH regarding these two articles published in @ASCO_pubs + @NEJM in lung cancer worth listenin…
RT @prat_aleix: valid points from @VPrasadMDMPH regarding these two articles published in @ASCO_pubs + @NEJM in lung cancer worth listenin…
RT @prat_aleix: valid points from @VPrasadMDMPH regarding these two articles published in @ASCO_pubs + @NEJM in lung cancer worth listenin…
RT @BoschBarrera: Vamos en la buena dirección, pero queda mucho camino para el objetivo del 75% de supervivencia en 2030 para el cáncer de…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @BoschBarrera: Vamos en la buena dirección, pero queda mucho camino para el objetivo del 75% de supervivencia en 2030 para el cáncer de…
RT @BoschBarrera: Vamos en la buena dirección, pero queda mucho camino para el objetivo del 75% de supervivencia en 2030 para el cáncer de…
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/lAiMKB2KhN
RT @BoschBarrera: Vamos en la buena dirección, pero queda mucho camino para el objetivo del 75% de supervivencia en 2030 para el cáncer de…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @BoschBarrera: Vamos en la buena dirección, pero queda mucho camino para el objetivo del 75% de supervivencia en 2030 para el cáncer de…
Vamos en la buena dirección, pero queda mucho camino para el objetivo del 75% de supervivencia en 2030 para el cáncer de pulmón. Muchos seguimos trabajando uniendo fuerzas para hacerlo realidad @gecp_org.
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @jsoriamd: Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to…
RT @prat_aleix: valid points from @VPrasadMDMPH regarding these two articles published in @ASCO_pubs + @NEJM in lung cancer worth listenin…
Lung cancer remains a major killer but significant improvements in care have been made these last 10 years which have led to improved survival https://t.co/dtKBvegzFt https://t.co/BN0sFX68HQ
RT @prat_aleix: valid points from @VPrasadMDMPH regarding these two articles published in @ASCO_pubs + @NEJM in lung cancer worth listenin…
RT @prat_aleix: valid points from @VPrasadMDMPH regarding these two articles published in @ASCO_pubs + @NEJM in lung cancer worth listenin…
valid points from @VPrasadMDMPH regarding these two articles published in @ASCO_pubs + @NEJM in lung cancer worth listening! @SoundCloud: https://t.co/uj5XziOA7j https://t.co/8WrA3ZPn62 https://t.co/Y7YTmDOt11 https://t.co/IK7CsKAIgd
RT @CBelaniMD: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/laMAuugEYw Reduction in incidenc…
RT @NReguart: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | @NEJM https://t.co/NMXsB7oerd https://t.co/8rlIJ…
RT @CBelaniMD: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/laMAuugEYw Reduction in incidenc…
RT @NReguart: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | @NEJM https://t.co/NMXsB7oerd https://t.co/8rlIJ…
RT @NReguart: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | @NEJM https://t.co/NMXsB7oerd https://t.co/8rlIJ…
米国の非小細胞肺癌の死亡率は,この数年で減少. 治療の進歩によるものと考えられる. NEJM https://t.co/NkMk3Ic0zM
Great to see declining #lungcancer death rates with better treatments like #immunotherapy and targeted agents. Hope to see more improvements in coming years. @NEJM https://t.co/CaXVjYreyV
RT @NReguart: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | @NEJM https://t.co/NMXsB7oerd https://t.co/8rlIJ…
RT @VPrasadMDMPH: It does not serve your constituency to be a cheerleader for a deeply flawed paper Best read this thread instead https://…
RT @VPrasadMDMPH: It does not serve your constituency to be a cheerleader for a deeply flawed paper Best read this thread instead https://…
RT @peterbachmd: Intriguing @theNCI @NCIDrDougLowy @NEJM study showing lung cancer mortality rates falling since 2013 faster than incidence…
Re-read paper. Can't find analysis linking Rx & outcome, or correcting for changing stage distribution. How do you explain mortality decline greater in M than F when EGFR+ more common in F than M and you attribute (and label) decline to EGFR inhibitor
The Effect of Advances in Lung-Cancer Treatment on Population Mortality https://t.co/r3bwDTSiq6
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
RT @NReguart: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | @NEJM https://t.co/NMXsB7oerd https://t.co/8rlIJ…
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | @NEJM https://t.co/NMXsB7oerd https://t.co/8rlIJAUS6E
The Effect of Advances in Lung-Cancer Treatment on Population Mortality. https://t.co/Oe1kpO1n7F
RT @VPrasadMDMPH: I see Peter Bach's critical appraisal is also spot on 👇https://t.co/g474j77xxO
RT @peterbachmd: Intriguing @theNCI @NCIDrDougLowy @NEJM study showing lung cancer mortality rates falling since 2013 faster than incidence…
RT @RajVaddepally: It’s good to see the mortality improvement is seen across racial, ethnic, and gender groups. I fee there should be more…
It does not serve your constituency to be a cheerleader for a deeply flawed paper Best read this thread instead https://t.co/UKqViJo0fg
It’s good to see the mortality improvement is seen across racial, ethnic, and gender groups. I fee there should be more advocacy for LDCT apart from the therapeutics.
More power to precision oncology! NGS for #NSCLC
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
RT @NormandBlais: Diminution de la mortalité par cancer du poumon dans les dix dernières années. De nombreux facteurs associés. #cessertaba…
RT @NormandBlais: Diminution de la mortalité par cancer du poumon dans les dix dernières années. De nombreux facteurs associés. #cessertaba…
Diminution de la mortalité par cancer du poumon dans les dix dernières années. De nombreux facteurs associés. #cessertabac #TEP #SBRT #ImmunoRx #therapiesciblees The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/5w
US Mortality from NSCLC fell sharply from 2013 to 2016, and survival after diagnosis improved substantially due to both decreased incidence and improved treatment options. #pallonc #hapc #prognosticchanges https://t.co/blQmMKeA6H
RT @A_Schwa: Advances in lung cancer treatment may have reduced lung cancer mortality. But, this paper does not show it. I am very surprise…
RT @A_Schwa: Advances in lung cancer treatment may have reduced lung cancer mortality. But, this paper does not show it. I am very surprise…
wonderful time for thoracic oncologists
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
RT @JamesBatesMD: Better lung cancer treatment --> lower mortality Also a SEER study got accepted to the NEJM https://t.co/jdbuknuNNy
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
The Effect of Advances in Lung-Cancer Treatment on Population Mortality. https://t.co/muu2ELzUnE
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
RT @JamesBatesMD: Better lung cancer treatment --> lower mortality Also a SEER study got accepted to the NEJM https://t.co/jdbuknuNNy
RT @Cancer_talks: Reason for celebration from SEERs 2013-->2016: Mortality from NSCLC decreased even faster than the incidence https://t.…
RT @fred_hirsch: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/TSak96oH4b
A recent study shows that overall mortality from #lungcancer is on the decline in the United States. This is likely due to the advancement of treatment and the use of targeted therapies. https://t.co/RTsnY7Kum4 https://t.co/B8Ad6tuLiM
RT @CarrascalAlvaro: Pop.-level mortality from #lungcancer in the US fell sharply from 2013 to 2016 (among men, incidence-based mortality d…
RT @AnkitBharatMD: A lot of innovation is needed for lung cancer but reassuring to know that we are making progress. @LurieCancer https:…